4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001834021-26-000004
See Remarks sold 58,333 shares at an average $12.64 ($737,410)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David See Remarks | 2026-07-09 | Sale 10b5-1 | −42,608 | $12.87 | $548,177 | 899,877 | D: show line 1 in the form |
| Kirn David See Remarks | 2026-07-10 | Sale 10b5-1 | −15,283 | $12.01 | $183,560 | 884,594 | D: show line 2 in the form |
| Kirn David See Remarks | 2026-07-10 | Sale 10b5-1 | −442 | $12.84 | $5,673 | 884,152 | D: show line 3 in the form |
| Open-market sales · 58,333 sh · avg $12.64 · $737,410 | |||||||
Loading xslF345X06/ownership.xml…